Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
The Journal of Chemical Physics|September 2, 2021
Simulation of protein pulling dynamics on second time scale with boxed molecular dynamicsSarah Mapplebeck, Jonathan Booth, Dmitrii ShalashilinPhysical Chemistry Chemical Physics : PCCP|June 20, 2018
An ab initio multiple cloning approach for the simulation of photoinduced dynamics in conjugated moleculesVictor M Freixas, Sebastian Fernandez-Alberti, Dmitry V Makhov, et al.The Journal of Physical Chemistry Letters|March 17, 2021
Nonadiabatic Excited-State Molecular Dynamics Methodologies: Comparison and ConvergenceVictor M Freixas, Alexander J White, Tammie Nelson, et al.The Journal of Physical Chemistry Letters|March 19, 2024
Dissociation of Hydrofluorocarbon Molecules after Electron Impact in PlasmaDmitry V Makhov, Gregory Armstrong, Hsiao-Han Chuang, et al.Diagnosis (Berlin, Germany)|March 16, 2018
Persistently raised aspartate aminotransferase (AST) due to macro-AST in a rheumatology clinicWycliffe Mbagaya, Joanne Foo, Ahai Luvai, et al.Journal of Pharmaceutical Sciences|May 29, 2014
Sucrose/Glucose molecular alloys by cryomillingAndrew J Megarry, Jonathan Booth, Jonathan BurleyClinical Kidney Journal|December 21, 2016
Adenine phosphoribosyltransferase deficiency in the United Kingdom: two novel mutations and a cross-sectional surveyGowrie S Balasubramaniam, Monica Arenas-Hernandez, Emilia Escuredo, et al.International Journal of Rheumatic Diseases|September 19, 2019
Circulating interleukin-6 as a biomarker in a randomized controlled trial of modified-release prednisone vs immediate-release prednisolone, in newly diagnosed patients with giant cell arteritisEmma Miler, Philip P Stapleton, Sarah Mapplebeck, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 9, 2013
Case report: recurrent acute pancreatitis secondary to papillary somatostatinoma--a new associationTim Ambrose, Tim J Stephenson, Jonathan Booth, et al.International Journal of Rheumatic Diseases|August 10, 2017
A 26-week feasibility study comparing the efficacy and safety of modified-release prednisone with immediate-release prednisolone in newly diagnosed cases of giant cell arteritisCharles Raine, Philip P Stapleton, Dimos Merinopoulos, et al.Pageof 5